Variant report
Variant | esv3452493 |
---|---|
Chromosome Location | chr1:150210095-150211365 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:61)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:150210352-150210402 | HEEpiC | esophagus: | n/a |
2 | chr1:150210352-150210402 | IMR90 | lung: | fetal |
3 | chr1:150210352-150210402 | SAEC | small airway: | n/a |
4 | chr1:150210352-150210402 | GM12891 | blood: | n/a |
5 | chr1:150210352-150210402 | AoSMC | blood vessel: | n/a |
6 | chr1:150210352-150210402 | PrEC | prostate: | n/a |
7 | chr1:150210352-150210402 | A549 | lung: | n/a |
8 | chr1:150210352-150210402 | NB4 | blood: | n/a |
9 | chr1:150210352-150210402 | HRPEpiC | eye: | n/a |
10 | chr1:150210352-150210402 | Jurkat | blood: | n/a |
11 | chr1:150210352-150210402 | RPTEC | kidney: | n/a |
12 | chr1:150210352-150210402 | MCF-7 | breast: | n/a |
13 | chr1:150210352-150210402 | ProgFib | skin: | n/a |
14 | chr1:150210352-150210402 | SK-N-MC | brain: | n/a |
15 | chr1:150210352-150210402 | GM06990 | blood: | n/a |
16 | chr1:150210352-150210402 | NT2-D1 | testis: | n/a |
17 | chr1:150210352-150210402 | HepG2 | liver: | n/a |
18 | chr1:150210352-150210402 | AG09309 | skin: | n/a |
19 | chr1:150210352-150210402 | AG04449 | skin: | fetal |
20 | chr1:150210352-150210402 | H1-hESC | embryonic stem cell: | embryo |
21 | chr1:150210352-150210402 | HUVEC | blood vessel: | n/a |
22 | chr1:150210352-150210402 | SK-N-SH | brain: | n/a |
23 | chr1:150210352-150210402 | T-47D | breast: | n/a |
24 | chr1:150210352-150210402 | NHDF-neo | bronchial: | n/a |
25 | chr1:150210352-150210402 | MCF10A-Er-Src | breast: | n/a |
26 | chr1:150210352-150210402 | Caco-2 | colon: | n/a |
27 | chr1:150210352-150210402 | PANC-1 | pancreas: | n/a |
28 | chr1:150210352-150210402 | AG09319 | gingival: | n/a |
29 | chr1:150210352-150210402 | K562 | blood: | n/a |
30 | chr1:150210352-150210402 | HMEC | breast: | n/a |
31 | chr1:150210352-150210402 | ovcar-3 | ovarian: | n/a |
32 | chr1:150210352-150210402 | Hela-S3 | cervix: | n/a |
33 | chr1:150210352-150210402 | HCT-116 | colon: | n/a |
34 | chr1:150210352-150210402 | SK-N-SH_RA | brain: | n/a |
35 | chr1:150210352-150210402 | U87 | brain: | n/a |
36 | chr1:150210352-150210402 | Hepatocyte | liver: | n/a |
37 | chr1:150210352-150210402 | HIPEpiC | eye: | n/a |
38 | chr1:150210352-150210402 | HCM | heart: | n/a |
39 | chr1:150210352-150210402 | NHBE | bronchial: | n/a |
40 | chr1:150210352-150210402 | HL-60 | blood: | n/a |
41 | chr1:150210352-150210402 | BE2_C | brain: | n/a |
42 | chr1:150210352-150210402 | LNCaP | prostate: | n/a |
43 | chr1:150210352-150210402 | AG10803 | skin: | n/a |
44 | chr1:150210352-150210402 | HCF | heart: | n/a |
45 | chr1:150210352-150210402 | GM12878 | blood: | n/a |
46 | chr1:150210352-150210402 | HRE | kidney: | n/a |
47 | chr1:150210352-150210402 | HNPCEpiC | eye: | n/a |
48 | chr1:150210352-150210402 | ECC-1 | luminal epithelium: | n/a |
49 | chr1:150210352-150210402 | HRCEpiC | kidney: | n/a |
50 | chr1:150210352-150210402 | HPAEpiC | pulmonary alveolar: | n/a |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:150206250..150210524-chr1:150335148..150338813,9 | MCF-7 | breast: | |
2 | chr1:150209914..150212517-chr1:150228634..150232834,3 | K562 | blood: | |
3 | chr1:150207682..150210552-chr1:150291812..150294121,3 | K562 | blood: | |
4 | chr1:150203436..150211066-chr1:150333611..150339492,20 | K562 | blood: | |
5 | chr1:149857476..149860799-chr1:150206355..150210783,8 | K562 | blood: | |
6 | chr1:150207085..150210384-chr1:150292615..150294360,3 | K562 | blood: | |
7 | chr1:150039411..150040952-chr1:150209636..150212635,2 | K562 | blood: | |
8 | chr1:150206579..150210456-chr1:150238390..150242863,9 | MCF-7 | breast: | |
9 | chr1:150205879..150210456-chr1:150251557..150256195,8 | MCF-7 | breast: | |
10 | chr1:150198495..150205043-chr1:150206226..150211170,11 | MCF-7 | breast: | |
11 | chr1:150209725..150211414-chr1:150230060..150232543,2 | K562 | blood: | |
12 | chr1:150205053..150211036-chr1:150333116..150338498,15 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANP32E | TF binding region |
ANP32E | CpG island |
ENSG00000118298 | chromatin interactions |
ENSG00000117362 | chromatin interactions |
ENSG00000184678 | chromatin interactions |
ENSG00000143401 | chromatin interactions |
ENSG00000163125 | chromatin interactions |
ENSG00000184260 | chromatin interactions |
ENSG00000271845 | chromatin interactions |
ENSG00000136631 | chromatin interactions |
ENSG00000184270 | chromatin interactions |
ENSG00000117360 | chromatin interactions |
ENSG00000159208 | chromatin interactions |
ENSG00000118292 | chromatin interactions |
ENSG00000178096 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368217747 | chr1:150210098-150210099 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
2 | rs11205347 | chr1:150210120-150210121 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 14 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs587605984 | chr1:150210122-150210123 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
4 | rs587653678 | chr1:150210156-150210157 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
5 | rs587737438 | chr1:150210171-150210172 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
6 | rs145900188 | chr1:150210216-150210217 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
7 | rs112768027 | chr1:150210249-150210250 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
8 | rs587738822 | chr1:150210257-150210258 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
9 | rs12057743 | chr1:150210306-150210307 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs587688129 | chr1:150210329-150210330 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
11 | rs78150327 | chr1:150210346-150210347 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
12 | rs587619582 | chr1:150210352-150210353 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
13 | rs181930284 | chr1:150210360-150210361 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
14 | rs587774632 | chr1:150210369-150210370 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
15 | rs60883600 | chr1:150210415-150210416 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 14 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs587715545 | chr1:150210425-150210426 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 14 gene(s) | Overlapped CNVs | n/a |
17 | rs587771524 | chr1:150210474-150210475 | Weak transcription Enhancers | Chromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
18 | rs587641432 | chr1:150210529-150210530 | Weak transcription Enhancers | Chromatin interactive region | 10 gene(s) | Overlapped CNVs | n/a |
19 | rs6655935 | chr1:150210538-150210539 | Weak transcription Enhancers | Chromatin interactive region | 10 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs150719032 | chr1:150210555-150210556 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
21 | rs587636305 | chr1:150210578-150210579 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
22 | rs587726509 | chr1:150210579-150210580 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
23 | rs374956911 | chr1:150210591-150210592 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
24 | rs587604891 | chr1:150210631-150210632 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
25 | rs55719183 | chr1:150210792-150210793 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
26 | rs190033608 | chr1:150210902-150210903 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
27 | rs587714275 | chr1:150210916-150210917 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
28 | rs587610971 | chr1:150210918-150210919 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
29 | rs113204265 | chr1:150210957-150210958 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
30 | rs587743495 | chr1:150210975-150210976 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
31 | rs369008837 | chr1:150210983-150210984 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
32 | rs143074643 | chr1:150210986-150210987 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
33 | rs146116790 | chr1:150210992-150210993 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
34 | rs587635788 | chr1:150210994-150210995 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
35 | rs112573499 | chr1:150211033-150211034 | Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
36 | rs587770968 | chr1:150211087-150211088 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs202024423 | chr1:150211103-150211104 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs148744989 | chr1:150211104-150211105 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs10157434 | chr1:150211153-150211154 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs185838579 | chr1:150211173-150211174 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs191256108 | chr1:150211182-150211183 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs587761301 | chr1:150211250-150211251 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs143689123 | chr1:150211304-150211305 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs587724586 | chr1:150211324-150211325 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21611746 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Cancer | 23975201 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Schizophrenia | 19805367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:150209000-150212000 | Weak transcription | Lung | lung |
2 | chr1:150209200-150215400 | Weak transcription | Right Atrium | heart |
3 | chr1:150209400-150210400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr1:150209400-150212000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
5 | chr1:150209600-150210200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr1:150209600-150210400 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr1:150209600-150212000 | Weak transcription | HepG2 | liver |
8 | chr1:150209600-150212200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
9 | chr1:150209600-150212400 | Weak transcription | GM12878-XiMat | blood |
10 | chr1:150209800-150210200 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr1:150209800-150210200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr1:150210000-150214800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr1:150210200-150210400 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr1:150210400-150210600 | Enhancers | Thymus | Thymus |